Answers are grounded in this paper and cite their sources.
Acne vulgaris and rosacea are common chronic inflammatory dermatoses with complex and multifactorial pathogenesis. Emerging evidence suggests that insulin resistance may contribute to their development or clinical expression through compensatory hyperinsulinemia, altered insulin-like growth factor-1 signalling, chronic low-grade inflammation, oxidative stress, and endothelial dysfunction. This narrative review summarizes current evidence regarding the relationship between insulin resistance, acne vulgaris, and rosacea. A targeted literature search was conducted in PubMed/MEDLINE for publications from January 2016 to August 2026. Additional relevant studies were identified through screening of the reference lists of systematic reviews, meta-analyses, and original clinical and mechanistic studies. Priority was given to publications addressing insulin resistance, hyperinsulinemia, HOMA-IR, insulin-like growth factor-1, mTORC1, acne vulgaris, rosacea, metabolic abnormalities, oxidative stress, and dietary interventions. Observational studies and meta-analytic findings generally indicate higher insulin resistance indices among patients with acne than among controls. Potential mechanisms include activation of the PI3K/Akt/mTORC1 pathway, enhanced androgen signalling, sebaceous lipogenesis, follicular hyperkeratinisation, and inflammatory responses. Low-glycaemic-load dietary interventions and insulin-sensitizing treatment have shown potential benefits in selected patients, although the available evidence remains limited. The association between insulin resistance and rosacea is less clearly established. Small case-control studies have reported increased insulin resistance and metabolic abnormalities in patients with rosacea, whereas evidence from broader cardiometabolic studies remains inconsistent. Shared inflammatory, oxidative, and vascular mechanisms provide biological plausibility but do not establish causality. Insulin resistance may therefore represent a metabolic comorbidity or disease-modifying factor, particularly in acne vulgaris. Prospective studies using standardized metabolic assessments are needed to clarify causal relationships and determine whether improving insulin sensitivity affects dermatological outcomes.
No takes yet. Share an insight, caveat, or question.
Kuts et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: